Elizabeth Ahern

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Top Venues

Asia-Pacific journal of clinical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth Ahern, Ben J Solomon, Rina Hui, Nick Pavlakis, Ken O'Byrne, Brett G M Hughes
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time? Journal for immunotherapy of cancer 9 (6) (2021)
Ailin Lepletier, Jason Madore, Jake S O'Donnell, Rebecca L Johnston, Xian-Yang Li, Elizabeth McDonald, Elizabeth Ahern, Anna Kuchel, Melissa Eastgate, Sally-Ann Pearson, Domenico Mallardo, Paolo Antonio Ascierto, Daniela Massi, Barbara Merelli, Mario Mandala, James S Wilmott, Alexander M Menzies, Charles Leduc, Bertrand Routy, Georgina V Long, Richard A Scolyer, Tobias Bald, Nicola Waddell, William C Dougall, Michele W L Teng, Mark J Smyth
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Anna Kuchel, Elizabeth Ahern, Stephanie Collins, Vicki Whitehall, Satomi Okano, Anita Pelecanos, David Wyld, Melissa Eastgate, Matthew Burge
Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real-world multi-institution cohort study. Asia-Pacific journal of clinical oncology 17 (1) (2020)
Elizabeth Ahern, Michael J Allen, Andrew L Schmidt, Zarnie Lwin, Brett G M Hughes
Retrospective analysis of hospital admissions due to immune checkpoint inhibitor-induced immune-related adverse events (irAE). Asia-Pacific journal of clinical oncology 17 (2) (2020)
Elizabeth Ahern, Annette Cubitt, Emma Ballard, Michele W L Teng, William C Dougall, Mark J Smyth, David Godbolt, Rishendran Naidoo, Amanda Goldrick, Brett G M Hughes
Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN). Trials 20 (1) (2019)